REYON Pharmaceutical Co., Ltd.

KOSE:A102460 Voorraadrapport

Marktkapitalisatie: ₩262.5b

REYON Pharmaceutical Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Soon-Ock Jung

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO17.1%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

REYON Pharmaceutical Co., Ltd.'s (KRX:102460) Shareholders Might Be Looking For Exit

Oct 18
REYON Pharmaceutical Co., Ltd.'s (KRX:102460) Shareholders Might Be Looking For Exit

There May Be Reason For Hope In REYON Pharmaceutical's (KRX:102460) Disappointing Earnings

Mar 31
There May Be Reason For Hope In REYON Pharmaceutical's (KRX:102460) Disappointing Earnings

Consider This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For The 1.6% Dividend

May 08
Consider This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For The 1.6% Dividend

Here's Why REYON Pharmaceutical (KRX:102460) Has A Meaningful Debt Burden

Apr 09
Here's Why REYON Pharmaceutical (KRX:102460) Has A Meaningful Debt Burden

What Percentage Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Shares Do Insiders Own?

Feb 28
What Percentage Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Shares Do Insiders Own?

Read This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For Its Dividend

Jan 20
Read This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For Its Dividend

REYON Pharmaceutical (KRX:102460) Seems To Use Debt Quite Sensibly

Jan 02
REYON Pharmaceutical (KRX:102460) Seems To Use Debt Quite Sensibly

Did REYON Pharmaceutical's (KRX:102460) Share Price Deserve to Gain 50%?

Dec 12
Did REYON Pharmaceutical's (KRX:102460) Share Price Deserve to Gain 50%?

How Much Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Do Insiders Own?

Nov 24
How Much Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Do Insiders Own?

CEO

Soon-Ock Jung (74 yo)

no data

Tenure

Ms. Soon-Ock Jung serves as a Chairman and Chief Executive Officer of REYON Pharmaceutical Co., Ltd. She served as a Managing Director of REYON Pharmaceutical Co., Ltd.